CHGB · Partner-reported service scope
Pathogenic Gene Analysis
Comprehensive genetic disease diagnosis and birth defect prevention across the full care continuum, from premarital and preconception screening through newborn genomic screening.
- Partner-reported scope
- 1,000+ disease panels
- Method
- NGS · sub-exome sequencing
CHGB · Partner-reported
Service capabilities
The following scope is reported by the partner. Quantities describe the partner portfolio and do not represent VectorGene’s own track record.
- Premarital & preconception screening
- Including health education programmes.
- Carrier screening
- Severe pathogenic variants.
- Preimplantation genetic diagnosis (PGD)
- Prenatal diagnosis
- Non-invasive chromosomal and de novo mutation testing, plus invasive sub-exome sequencing.
- Newborn genomic screening (gNBS)
- Developmental assessment
- Early detection, intervention and treatment emphasis.
- Functional birth defect panels
- Epilepsy, autism, precocious puberty, developmental delay.
- Pre-symptomatic & polygenic risk
- Monogenic late-onset and common disease.
- Genetic counselling capability building
Interpret a finding in its clinical and family context.
A gene-analysis brief should explain why testing is being considered, which genes or variant types are in scope and what information accompanies the sample. Institutions can then assess the method, reporting process and support needed when a result is uncertain or raises questions for relatives.
Genetic results are interpreted alongside the test’s purpose and personal and family history. A negative result can leave questions unresolved, and an uncertain variant does not establish or exclude a diagnosis.
MedlinePlus Genetics: What do the results of genetic tests mean?External references explain the wider context. They do not verify or endorse the supplied VectorGene or partner offering.
Questions for the programme brief
What question is being investigated?
Record the phenotype, relevant family history and whether the proposed test is diagnostic, carrier or predictive testing.
What can the assay detect?
Request the gene and variant scope, validation evidence, coverage limitations and rules for additional testing.
How are findings communicated?
Agree variant review, counselling, uncertain-result handling and the process for later reinterpretation.
What to prepare for review
- Clinical question and test scope
- Sample requirements and assay limitations
- Reporting and counselling pathway
Working environments
Genomics work, in context.
Illustrative stock photography provides context for the people, processes and working environments behind this capability.
